One of the biggest misconceptions is that iron deficiency and anaemia are interchangeable The challenge is that iron deficiency doesn't always show up in the way people expect. You don't need to have ...

An Azov fighter recounted the horrors of Horlivka, run-ins with the FSB, and return to Ukraine An Azov fighter, Serhii Bentsa, survived years of captivity, brutal torture, and information isolation ...

A wave of cannabis-related research published in 2026 has examined the plant’s potential impact on pain, cancer, neurological ...

MIT and Harvard scientists have designed an advanced type of immune cell called a CAR-NK cell that can destroy cancer while avoiding attack from the body’s own immune defenses. This innovation could ...

Approximately 30%-50% of patients with relapsed or refractory B-cell non-Hodgkin lymphomas have achieved durable remissions with CAR T-cell therapies targeting CD19 over follow-up periods of up to 5 ...

The human-made cells show many hallmarks of life, but they can't make all their necessary internal structures or divide for that many generations ...

How does a single cell build a brain with billions of precisely organized neurons? Researchers suggest that brain cells use their lineage—their cellular family tree—as a kind of positional map. Cells ...

Scientists say they have built a cell from scratch for the first time that feeds, grows and replicates like a natural cell, a breakthrough in synthetic biology.

A single infusion of a genetically reprogrammed immune cell therapy produced confirmed cancer-free survival in more than one-third of large B-cell lymphoma patients and nearly half of follicular ...

Anti-CD19 chimeric antigen receptor (CAR) T-cell therapy is a standard treatment for relapsed or refractory B-cell non-Hodgkin lymphomas. Long-term results and curative potential remain uncertain. We ...